dacarbazine has been researched along with Exanthem in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, SE; Baurain, JF; Butler, MO; Carvajal, RD; Curti, B; Demidov, L; Dummer, R; Gastaud, L; Goodall, H; Hamid, O; Hassel, JC; Holland, C; Joshua, AM; Kirkwood, JM; Mauch, C; Milhem, M; Nathan, P; Ochsenreither, S; Orloff, M; Piperno-Neumann, S; Piulats, JM; Rutkowski, P; Sacco, JJ; Salama, AKS; Schlaak, M; Shoushtari, AN; Sullivan, RJ; Yushak, M | 1 |
| Bardhi, R; Daveluy, S; Farshchian, M | 1 |
| Aamdal, S; Bondarenko, I; Chen, TT; Chiarion-Sileni, V; Garbe, C; Grob, JJ; Maio, M; Robert, C; Testori, A; Thomas, L; Tschaika, M; Wolchok, JD | 1 |
| Dinapoli, L; Maschio, M; Muti, P; Vidiri, A | 1 |
| Alonso-Llamazares, A; Beitia-Mazuecos, JM; Cardenas-Contreras, R; Mateo-Borrega, B; Vega-Castro, A | 1 |
| Carrato Mena, A; Guillén Ponce, C; Maciá Escalante, S; Rodríguez Lescure, A; Ull Laita, M | 1 |
2 trial(s) available for dacarbazine and Exanthem
| Article | Year |
|---|---|
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cytokine Release Syndrome; Dacarbazine; Exanthema; Female; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Recombinant Fusion Proteins; Survival Analysis; Uveal Neoplasms | 2021 |
Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diarrhea; Drug Administration Schedule; Exanthema; Female; Humans; Ipilimumab; Kaplan-Meier Estimate; Male; Melanoma; Middle Aged; Pruritus; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Vitiligo | 2015 |
4 other study(ies) available for dacarbazine and Exanthem
| Article | Year |
|---|---|
Desquamative skin rash associated with temozolomide in a patient with glioblastoma.
Topics: Brain Neoplasms; Dacarbazine; Exanthema; Glioblastoma; Humans; Temozolomide | 2021 |
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.
Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Epilepsy; Exanthema; Female; Humans; Male; Middle Aged; Oxcarbazepine; Radiotherapy; Temozolomide | 2010 |
Rapid desensitization with temozolomide in patients with delayed maculopapular rash.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Female; Glioma; Humans; Hypersensitivity, Delayed; Immune Tolerance; Skin Tests; Temozolomide | 2012 |
[Male patient with Hodgkin's disease with exanthema of the gall bladder with symmetric distribution in hands after chemotherapy treatment].
Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Eruptions; Exanthema; Gallbladder Diseases; Hand Dermatoses; Hodgkin Disease; Humans; Male; Vinblastine | 2006 |